TREACE JOHN T. (Chief Executive Officer) purchased 0.8% of their position (50K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $265.6K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/17/2024ACC: 0000950170-24-107401
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+50K
Net shares
Net buyer
$265.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
$5.31
Trade value
$265.63K
% of position
0.8%
9/16/2024
6.47M→6.52M
Total
Net shares
+50K
Net value
$265.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2024 | P · Purchase | +50K | $5.31 | $265.63K | 0.8% | 6.47M | 6.52M |
| Total | +50K | $265.63K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.60M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.60M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported